Cargando…

Design of a chitosan-based nano vaccine against epsilon toxin of Clostridium perfringens type D and evaluation of its immunogenicity in BALB/c mice

BACKGROUND AND PURPOSE: Clostridium perfringens is an anaerobic, spore-forming, and pathogenic bacterium that causes intestinal diseases in humans and animals. In these cases, therapeutic intervention is challenging; because the disease progresses much rapidly. This bacterium can produce 5 main toxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poorhassan, Farnaz, Nemati, Fahimeh, Saffarian, Parvaneh, Mirhosseini, Seyed Ali, Motamedi, Mohammad Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562408/ https://www.ncbi.nlm.nih.gov/pubmed/34760006 http://dx.doi.org/10.4103/1735-5362.327504

Ejemplares similares

The pore structure of Clostridium perfringens epsilon toxin
por: Savva, Christos G., et al.
Publicado: (2019)

Is Clostridium perfringens epsilon toxin associated with multiple sclerosis?
por: Titball, Richard W, et al.
Publicado: (2023)

Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis
por: Wagley, Sariqa, et al.
Publicado: (2018)

Evidence for a Prepore Stage in the Action of Clostridium perfringens Epsilon Toxin
por: Robertson, Susan L., et al.
Publicado: (2011)

Clostridium perfringens Epsilon Toxin: A Malevolent Molecule for Animals and Man?
por: Stiles, Bradley G., et al.
Publicado: (2013)

Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens
por: Dorca-Arévalo, Jonatan, et al.
Publicado: (2020)

Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes
por: Shetty, Samantha V., et al.
Publicado: (2023)

Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants
por: Moreira, Gustavo Marçal Schmidt Garcia, et al.
Publicado: (2016)

Immunogenicity assessment of Clostridium perfringens type D epsilon toxin epitope-based chimeric construct in mice and rabbit
por: Singh, Ajay Pratap, et al.
Publicado: (2020)

Oligomerization of Clostridium perfringens Epsilon Toxin Is Dependent upon Caveolins 1 and 2
por: Fennessey, Christine M., et al.
Publicado: (2012)

Clostridium perfringens Epsilon Toxin Increases the Small Intestinal Permeability in Mice and Rats
por: Goldstein, Jorge, et al.
Publicado: (2009)

Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin
por: Alves, Guilherme Guerra, et al.
Publicado: (2017)

Proteolytic Processing and Activation of Clostridium perfringens Epsilon Toxin by Caprine Small Intestinal Contents
por: Freedman, John C., et al.
Publicado: (2014)

Correction: Clostridium perfringens Epsilon Toxin Increases the Small Intestinal Permeability in Mice and Rats
por: Goldstein, Jorge, et al.
Publicado: (2013)

Clostridium perfringens epsilon toxin binds to erythrocyte MAL receptors and triggers phosphatidylserine exposure
por: Geng, Zhijun, et al.
Publicado: (2020)

Pathology and Pathogenesis of Brain Lesions Produced by Clostridium perfringens Type D Epsilon Toxin
por: Finnie, John W., et al.
Publicado: (2022)

Clostridium perfringens Epsilon Toxin Targets Granule Cells in the Mouse Cerebellum and Stimulates Glutamate Release
por: Lonchamp, Etienne, et al.
Publicado: (2010)

Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide
por: Gil, Carles, et al.
Publicado: (2015)

Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines
por: Ferreira, Marcos Roberto A., et al.
Publicado: (2016)

Hemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors
por: Gao, Jie, et al.
Publicado: (2018)

Clostridium perfringens Epsilon Toxin Compromises the Blood-Brain Barrier in a Humanized Zebrafish Model
por: Adler, Drew, et al.
Publicado: (2019)

Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies
por: Bokori-Brown, Monika, et al.
Publicado: (2013)

Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination
por: Linden, Jennifer R., et al.
Publicado: (2015)

Clostridium perfringens epsilon toxin vaccine candidate lacking toxicity to cells expressing myelin and lymphocyte protein
por: Morcrette, Helen, et al.
Publicado: (2019)

Epsilon Toxin from Clostridium perfringens Causes Inhibition of Potassium inward Rectifier (Kir) Channels in Oligodendrocytes
por: Bossu, Jean Louis, et al.
Publicado: (2020)

Immunization with recombinant fusion of LTB and linear epitope (40–62) of epsilon toxin elicits protective immune response against the epsilon toxin of Clostridium perfringens type D
por: Kaushik, Himani, et al.
Publicado: (2019)

Correlation between In Vitro Cytotoxicity and In Vivo Lethal Activity in Mice of Epsilon Toxin Mutants from Clostridium perfringens
por: Dorca-Arévalo, Jonatan, et al.
Publicado: (2014)

Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens
por: Rumah, Kareem R., et al.
Publicado: (2017)

New Mutants of Epsilon Toxin from Clostridium perfringens with an Altered Receptor-Binding Site and Cell-Type Specificity
por: Dorca-Arévalo, Jonatan, et al.
Publicado: (2022)

Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
por: Ma, Yinghua, et al.
Publicado: (2023)

Recombinant expression of in silico identified Bcell epitope of epsilon toxin of Clostridium perfringens in translational fusion with a carrier protein
por: Kaushik, Himani, et al.
Publicado: (2013)

A Novel Panel of Rabbit Monoclonal Antibodies and Their Diverse Applications Including Inhibition of Clostridium perfringens Epsilon Toxin Oligomerization
por: Linden, Jennifer R., et al.
Publicado: (2018)

Clostridium perfringens Epsilon-Toxin Impairs the Barrier Function in MDCK Cell Monolayers in a Ca(2+)-Dependent Manner
por: Nagahama, Masahiro, et al.
Publicado: (2020)

Regulation of Toxin Production in Clostridium perfringens
por: Ohtani, Kaori, et al.
Publicado: (2016)

Production, immunogenicity, stability, and safety of a vaccine against Clostridium perfringens beta toxins
por: Saadh, Mohamed J., et al.
Publicado: (2020)

Sialidases Affect the Host Cell Adherence and Epsilon Toxin-Induced Cytotoxicity of Clostridium perfringens Type D Strain CN3718
por: Li, Jihong, et al.
Publicado: (2011)

Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL
por: Linden, Jennifer R., et al.
Publicado: (2019)

Interaction of Clostridium perfringens Epsilon Toxin with the Plasma Membrane: The Role of Amino Acids Y42, Y43 and H162
por: Marshall, Skye, et al.
Publicado: (2022)

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice
por: Hosseini, Zahra Sadat, et al.
Publicado: (2018)

Immunogenicity of a newly developed vaccine against Clostridium perfringens alpha-toxin in rabbits and cattle
por: Saadh, Mohamed J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7ui3579rrq2g3brq14lkcsact